A 2 X 2 factorially arranged trial was conducted to compare effects of implant (zeranol) and frame size on weight and compositional gain, and plasma hormone concentrations. Angus, Charohis • Hereford and Hereford • Angus yearling steers (34 steers averaging 270 kg body weight) were randomly assigned to treatments of small (SF) vs large frame (LF) and implant (I) vs no implant (NI). Steers were implanted at 0 and 97 d and individually fed an 81% whole shelled corn and 11.5% corn silage-based diet (dry basis) for a 175-d period. Shrunk weights and body measurements for frame size determination were taken initially and at approximately 28-d intervals; blood was collected via venipuncture at 14-d intervals for analyses of insulin (IN), triiodothyronine (T a ), thyroxine (T 4) and glucose concentrations. Steers were also counted in a whole body counter for measurement of 40 K content and prediction of whole body protein and fat. The I steers showed an improvement (P<.05) in daily gain regardless of frame size for the total trial. The I LF steers required 18% more dry matter to attain higher daily gain for97 to 175 d; 1 steers were more efficient (P<.05) at converting dry matter to gain during 0 to 97 d and 0 to 175 d. Daily fat deposition was increased (P<.05) in I steers, while protein deposition was not affected by I. Plasma IN concentrations were numerically elevated (P<.I 0) in I steers regardless of frame size, during the initial 97 d. Implant did not influence (P>.IO) plasma T3, T, and glucose concentrations regardless of frame size. Steers responded differently to zeranol implant over time regarding plasma T~ concentrations (P<.003). Steers differing in frame size responded similarly in rate of gain, in feed conversion and in patterns of plasma insulin concentrations to zeranol implants.
Introduction
A great deal of research has been performed in the area of growth regulation and its effect on body composition of beef cattle. Anabolic agents (both estrogenic and androgenic) have been used extensively to improve production of farm animals (Buttery et al., 1978; Heitzman, 1980) .
The implantation with estrogenic anabolic compounds (zeranol, diethylstilbesterol and estradiol benzoate/progesterone) has been shown to improve growth rate and affect protein metabolism of beef cattle (Sharp and Dyer, 1971; Rumsey et al., 1981) .
The mechanism of action by which these anabolic agents increase growth and alter body composition of cattle is not clearly understood. Buttery et al. (1978) suggested that anabolic agents mediate their effects by altering circulating concentrations of endogenous hormones. The anabolic estrogenic implants, however, vary in their effects on plasma circulating hormone concentrations (Davis et al., 1970; Trenkle, 1970; Grigsby, 1981; Gopinath and Kitts, 1984) . This suggests that estrogenic implants exert their growth-stimulating effect through different mechanisms.
The effects of anabolic estrogenic implants on plasma insulin (IN; Trenkle, 1970; Grigsby, 1981) , plasma triiodothyronine (T3) and plasma thyroxine (T4) concentrations (Grigsby, 1981; Gopinath and Kitts, 1984) have been inconsistent. Grigsby (1981) suggested that period of time after implanting before taking 1113 J. Anim. Sci. 1987 Sci. . 65:1113 Sci. -1123 blood samples may have been insufficient for estradiol to exert its effect on circulating endogenous hormone concentrations. Gopinath and Kitts (1984) also found variable responses in plasma T4 concentrations and no effect on plasma T3 concentrations to estradiol benzoate/ progesterone and zeranol implants. The growth response from estradiol implants has been shown to be influenced by frame size (Trenkle and Grigsby, 1979) . As demonstrated by Grigsby (1981) , plasma hormonal concentrations would be affected differently in large-vs small-type steers. The intent of this research was to determine effects of zeranol implant on growth, compositional growth and plasma hormone concentrations in finishing steers differing in frame size but similar in genetic background.
Materials and Methods
Large and small frame steers represented by Angus, Charolais • Hereford and Hereford • Angus breeds were obtained from three Missouri farms. These steers were approximately 12 mo of age and averaged 270 kg at the beginning of the trial. Twenty-four of the 34 steers had been implanted with zeranol approximately 100-d before this experiment, while the other 10 steers had not been implanted before the experiment. These 24 steers were randomly assigned so that each treatment contained six previously implanted steers. The three breeds were randomly assigned so that breeds were randomly assigned across treatment combinations. Cattle were individually fed in a partially covered, dirt-floor feedlot from February through October.
Using a Calan electronic gate system 4, steers were individually given ad libitum access to a diet of 81% whole shelled corn and 11.5% corn silage diet with an 8% supplement (dry basis), as shown in table 1.
Cattle were blocked by weight and randomly assigned to the appropriate treatments. The experiment was a 2 • 2 factorial arrangement with zeranol implant (I, implant vs NI, no implant) and frame score being the main effects. Steers were initially implanted at d 0 and reimplanted at d 97 of the experiment. Frame size was determined by a method 4American Calan, Inc., P. O. Box 307, Northwood, NH 03261. developed by Massey (1979) , with steers assigned to small frame (SF) and large frame (LF) having mean frame scores of 2.2 and 3.5, respectively (table 2) .
On d 18 of the experiment and at 28-d intervals from d 0, steers were weighed after fasting from feed and water for 18 h, and then washed thoroughly to remove external contamination before being counted in the Whole Body Counter. Two l-rain counts of 4~ activity were determined for each steer by methods described by Coffman (1968) , using a two-pi liquid scintillation detector. Equations for predicting body composition were developed by multiple regression of chemical analyses of carcasses upon 4~ estimates of total body K and body protein (Clark et al., 1976) . When 4~ and live weight were used in combination to predict empty body N and fat content, the R 2 values were .83 and .87, respectively, for steer weights ranging from 183 to 574 kg. Corrections for ef- aFrom Massey (1979) .
ficiency, geometry and background depression were linear. Body composition was calculated by regression equations developed by Clark et al. (1976) :
.5415] • 6.25, .0012 R 2 = .83 and (BW X .099) -(K x .025) + .735, SD = .028 R 2 --.87, where total body K (g) and BW --body weight (kg). Protein and fat masses (kg) were calculated as percent protein and fat x body weight.
Corn silage was sampled twice a week and dried at 55 C, allowed to equilibrate and ground through a 1-mm screen. The net energy for maintenance (NEm) and net energy for gain (NEg) for corn silage were determined by conducting an in vitro dry matter disappearance (IVDMD) using a modified Tilley and Terry (1963) procedure. The IVDMD values for corn silage were entered into regression equations (%TDN = 16.7 +.74 X IVDMD, NEm = 1.32 • TDN -13.2, NEg = 1.32 • TDN --45.9; Van Soest, 1973) . The NEg and NEm values for corn and remaining dietary constituents were determined from table values (NRC, 1984) . According to procedures established by Lipsey et al. (1978) , the dry matter (DM) intake for maintenance was determined by dividing NEm requirements per day for each steer by NEm of the feedstuff. Available net energy for production (NEp) was determined by subtracting DM required for maintenance from total DM intake during each period and multiplying by the calculated value for NEg. The NEp to gain conversion (NEC) was calculated by available NEp divided by individual weight gain during each period.
Jugular blood samples were collected in heparinized syringes at approximately 0800 to 0900 and 18 h after feeding by venipuncture at 14-d intervals beginning on d 0 and ending on d 126. Samples were centrifuged at 1,200 x g for 10 min at 2 C and stored at -20 C for plasma glucose, IN, T3 and T4 analyses.
Plasma glucose was determined colorimetrically utilizing the linear enzymatic glucose procedure s .
Plasma IN, T3 and T4 were analyzed using solid phase 12si radioimmunoassay Coat-ACount kits 6 in which labeled 12si insulin, T3 and T 4 competes with IN, T3 and T4 in the sample for specific sites on antibody-coated tubes. Due to the presence of a blocking agent that releases bound T3 and T4 from carrier proteins, Ta and T 4 analyses are measurements of total T3 and T4. Each assay contained controls of high, normal and low concentrations and solutions consisting of IN, T3 or T4 standards and steer plasma in a 1:1 ratio to monitor standard recovery. Quality control was maintained by plotting standard curves and recording total counts, maximum binding, standard percent bound and slopes for each assay. Initial qualifications were performed utilizing the Diagnositic kits to determine percent recovery, curve displacement and parallelism. Percent recovery was analyzed by spiking standards of each kit with bovine plasma in a 1:30 standard plasma dilution. Samples were then analyzed according to Diagnostic procedure for standard recovery. Curve displacement was determined by diluting bovine plasma samples in a 1:1 ratio with each IN, T3 and T4 standard and final values plotted against standard curves.
Statistical
Analysis. An analysis of variance was performed using GLM procedure (SAS, 1979) to evaluate daily gain, DM intake, DM-to-gain ratio, NEp, NEC, rates of protein and fat deposition and carcass data. The statistical model for these variables was a 2 • 2 factorial arrangement of treatments with main effects of frame size, implant and interaction between frame size and implant. A separate analysis was performed for each period. The one degree of freedom F-value from the analysis of variance was used to test differences between treatment effects. The plasma traits were analyzed as a split-plot in time. The main effects included frame size, implant and the interaction of frame size and implant. The subplot contained time and the interaction of time with main plot effects. Linear, quadratic and cubic orthogonal comparisons were made when interactions were significant.
Results and Discussion
As shown in table 3, LF steers had heavier (P<.05) initial and final weights than SF steers (40.9 kg). Implanting with zeranol increased (P<.05) daily gain of SF and LF steers for 0 to 97-d and for 97-to 175-d periods, respectively. The frame size effect (P<.05) revealed that LF steers had higher daily gains than SF steers during 97 to 175-d and 0 to 175-d periods. The higher daily gain for LF steers vs SF steers was attributed to differences in response to zeranol as influenced by physiological maturity. This finding supports that by Trenkle and Grigsby (1979) , who demonstrated that growth response to estradiol implant in steers fed a finishing diet was different between small vs large type steers. The DM intake was higher (P<.05) for LF steers than SF steers throughout the 175-d trial. During the 97 to 175-d period, I steers had higher (P<.05) DM intake than NI steers. Although approaching significance at P<.10, the I x F interaction suggested that the I had a greater effect on DM intake in LF steers vs SF steers. This I x F interaction for DM intake suggests that DM intake was responsible for greater increase in daily gain due to I in LF (15%) vs SF (7%) steers during the 97 to 175-d period. Implanting with zeranol improved (P<.05) DM-to-gain ratio for steers during the 0 to 97-d and 0 to 175-d periods.
During d 97 to 175 (table 4), net energy available for production (NEp) was affected (P<.05) by I, frame size and I x frame size interaction (P<.05). The I x frame size interaction was attributed to the higher NEp value for I LF steers as compared with NI LF steers (7.99 vs 5.7 Meal/d). The higher NEp for LF steers coincided with numerically higher daily gain and DM intake due to I in LF vs SF st'.ers. During d 97 to 175, the increase in DM intake for the I LF steers indicated that reimplanting stimulated feed intake in LF vs SF steers.
The NEC values (Mcal.d--l-Kg -1 gain) were only affected by I during d 0 to 97. The ability of zeranol to improve feed conversion, as well as rate of gain, has been demonstrated in lambs (Wilson et al., 1972) and steers (Nicholson et al., 1973) .
The final percent body protein and percent body fat contents of steers were influenced (P<.05) by zeranol and frame size (table 5) . The LF steers and I steers had higher % body fat contents. Zeranol exerted no effect (P>.10) on rate of protein deposition throughout the 175-d study. Rate of fat deposition (g/d), however, was increased (P<.05) by zeranol and frame size during each period of the trial. The increase in carcass fat with zeranol implant was contrary to previous reports (Terry, 1983; Byers et al., 1986) , demonstrating an increase in N retention and protein deposition in steers implanted with zeranol. Trenkle and Arnold (1977) revealed that cattle receiving estrogenic implants deposited more fat when fed corn grain than those fed corn silage. Ferrell et al. (1978) also found that feeding high levels of grain did not increase carcass protein but tended to increase carcass fat. Perhaps, the increase in fat deposition in steers receiving zeranol implants was attributed to the high energy finishing diet and its effect on increasing plasma insulin concentration, which is associated with lipogenesis. The numerical elevation in plasma insulin concentrations in implanted steers during initial and subsequent implanting with zeranol would support this conclusion.
Steers implanted with zeranol averaged 9.3 kg heavier (P<.05) in carcass weight than NI steers (table 6). Frame size also affected (P<.05) carcass weight, with LF steers having 9% greater carcass weight than that of SF steers. Although not significant, zeranol appeared to increase fat thickness more in SF steers than in LF steers when compared with NI steers (36 vs 0% improvement, respectively).
Regardless of frame size, steers implanted with zeranol showed numerical increases (P<.10) in plasma IN concentrations as compared with NI steers (figure 1). The greatest increase in plasma IN level occurred on d 42. This sarge in plasma IN concentration due to zeranol corresponds to the increase (P<.05) in growth by steers due to zeranol during the first 97 d. Previous reports (Davis et al., 1970 (Davis et al., , 1977 Trenkle, 1970) Grigsby (1981) found, however, no insulin response to estradiol administration by small-and medium-type steers. Changes in plasma IN concentrations during the 0 to 97-d period suggest that IN may respond indirectly to circulating zeranol. The elevation in plasma insulin concentration due to estrogenic compounds, like zeranol, has been attributed to a secondary response to plasma GH concentrations (Wagner et al., 1970) . These data would support that statement during the 0 to 97-d period. With the second I, there -~ was no effect (P>.20) of I on circulating plasma IN concentrations.
Plasma T 3 and T4 concentrations were not affected (P>.10) by either zeranol implant <~ (figures 2, 3). However, there was an I X time ~< interaction (P<.003) with a linear response (P<.05) in plasma Ta concentrations during the first 97 d of the trial. Grigsby (1981) and <w Heitzman (1980) found that estradiol and trenbolone acetate reduced plasma Ta concen-Z trations, while Gopinath and Kitts (1984) o observed no effect of zeranol on plasma T 3 and T4 concentrations. As reflected by the frame size effect (P<.06), these data indicate that SF ~ steers respond more rapidly to zeranol than LF steers, regarding changes in plasma T4 concene~ trations. The frame size effect (P<.06) for <Z plasma T4 concentrations suggests that steers differing in physiological maturity have differ-Z ent plasma T4 concentrations. This observation is supported by that of Grigsby (1981), who ,d observed lower plasma T4 concentrations in o implanted medium-and large-type steers than Z nonimplanted steers, while implanted smallframed steers had higher plasma T4 concentrations than NI steers. Williams et al. (1983) also 0 observed that crossbred steers of similar genetic background but differing in physiological maturity had significantly different plasma thyroid hormone concentrations. The effect of ~5 estrogenic implants, like zeranol, on thyroid function appear to be influenced by physiologi-< cal maturity.
As shown in figure 4 , plasma glucose concentrations were influenced (P<.05) by frame size. During the first 97 d, SF steers had higher concentrations of plasma glucose as compared with LF steers (85.8 vs 80.0 rag/100 ml, respectively, as shown in table 7). Implanting steers with one implant followed by a subsequent zeranol implant, however, had no effect (P>.10) on plasma glucose concentrations. These data agree with Olsen et al. (1977) , who demonstrated that zeranol treatment had no effect on glucose metabolism. Changes in plasma glucose concentrations over time were affected (P<.06) by frame size, with frame size resulting in a different cubic response (P<.05).
The effect of frame size on plasma glucose concentration was similar to data found by Williams et al. (1983) , in which SF crossbred steers had higher (P<.05) concentrations than LF steers during the finishing phase. The higher circulating concentrations of plasma glucose may be a function of lower energy demand of adipose tissue in SF steers as compared with LF steers. The lower rate of fat deposition in SF steers as compared with LF steers would support this conclusion. Zeranol implant elicited an improvement in daily gain and feed conversion in SF and LF steers, while LF steers had a higher overall daily gain and DM intake than SF steers. Although LF steers deposited fat as a faster rate, zeranol implant increased the rate of fat deposition in both types of steers. These improvements in weight gain occurred concomitantly with numerical elevations in insulin concentration in steers implanted with zeranol. The physiological maturity of steers affected the response of plasma T4 concentrations to implants and the response of plasma glucose concentrations. In general, zeranol implants produced an increase in fat deposition and changes in plasma concentrations of insulin in SF and LF steers.
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